Опухоли головы и шеи (Mar 2023)

Lenvatinib for the treatment of radioiodine-refractory differentiated thyroid cancer: treatment optimization for maximum clinical benefit

  • L. J. Wirth,
  • C. Durante,
  • D. J. Topliss,
  • E. Winquist,
  • E. Robenshtok,
  • H. Iwasaki,
  • M. Luster,
  • R. Elisei,
  • S. Leboulleux,
  • M. Tahara

DOI
https://doi.org/10.17650/2222-1468-2022-12-4-81-90
Journal volume & issue
Vol. 12, no. 4
pp. 81 – 90

Abstract

Read online

.

Keywords